---
title: Impact of the Novel MRI Contrast Agent Gadopiclenol on Radiotherapy Decision
  Making in Patients With Brain Metastases
date: '2024-08-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39159365/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240820182437&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Gadopiclenol-enhanced MRI improved BM detection and characterization,
  with a direct impact on radiotherapy treatment decision between WBRT and SRS. Additionally,
  a more exact target delineation and planning could be performed with gadopiclenol.
  A prospective evaluation in a larger cohort of patients is required to confirm these
  ...'
disable_comments: true
---
CONCLUSIONS: Gadopiclenol-enhanced MRI improved BM detection and characterization, with a direct impact on radiotherapy treatment decision between WBRT and SRS. Additionally, a more exact target delineation and planning could be performed with gadopiclenol. A prospective evaluation in a larger cohort of patients is required to confirm these ...